This is a company that has consistently delivered strong results, one quarter after another, and over the last year they haven't gotten credit for it.

If J&J is not willing to up their bid, I think Guidant will be going to Boston Scientific.

I'm not actually surprised. I think it's to be expected.

The turmoil in the boardroom and the goings-on with the CEO succession should dominate the agenda.

It's just a lot more certain. It's a bird in the hand, and better than two birds in the bush.

There's a noticeable shift away from carbonated drink consumption and toward bottled water and health drinks.

That's going to be one of the big questions on everyone's mind. There is going to be a lot of pressure on them to provide some path and explanation of that path. They have a lot on their plate.

There is so much uncertainty involved. You just have a wild card pretty much everywhere you look.

I think there's always going to be a group of people who are willing to do that, especially as you get more empty nesters. In those households, the pet takes on incredible importance as a member of the family and people are willing to shell out incredible amounts of money to keep them healthy.

Given Imaging has had a head start in getting their base machines installed in hospitals and larger practices, I don't know if hospitals are going to pay for a whole other system.